NCT05173935

Brief Summary

The purpose of the study is to compare pain, complications, and quality of life after gastrostomy tube is placed by either percutaneous endoscopic gastrostomy (PEG) or radiologically-inserted gastrostomy (RIG) method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 29, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 30, 2021

Completed
Last Updated

January 11, 2023

Status Verified

January 1, 2023

Enrollment Period

3.6 years

First QC Date

November 29, 2021

Last Update Submit

January 10, 2023

Conditions

Keywords

complicationquality of lifepain

Outcome Measures

Primary Outcomes (6)

  • Change in pain with gastrostomy-tube placement, comparing RIG with PEG

    Trajectory of the average pain score over time (question 3, Cleeland Brief Pain Inventory), which rates average pain in the past 24 hours, with 0 being no pain and 10 being pain as bad as can be imagined

    Before the procedure, within 24 hours after procedure, at 48-96 hours after procedure, and at 6 weeks after procedure

  • Major and minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following major complications after procedure: Peritonitis, Abscess, Major bleeding requiring intervention and/or transfusion, Bowel perforation, Death; Assessment of the following minor complications after procedure: Minor bleeding, not requiring transfusion, Tube occluded, Tube malpositioned/fell out,Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    Within 24 hours after procedure

  • Major and minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following major complications after procedure: Peritonitis, Abscess, Major bleeding requiring intervention and/or transfusion, Bowel perforation, Death; Assessment of the following minor complications after procedure: Minor bleeding, not requiring transfusion, Tube occluded, Tube malpositioned/fell out,Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    At 6 weeks after procedure

  • Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    At 3 months, if tube still in place

  • Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    At 6 months, if tube still in place

  • Minor complications with gastrostomy-tube placement, comparing RIG with PEG

    Assessment of the following complications after procedure: Tube occluded, Tube malpositioned/fell out, Tube damaged, Skin erosion, Site redness, Site nodules/induration, Site exudate

    At 9 months, if tube still in place

Secondary Outcomes (4)

  • Costs associated with gastrostomy tube placement, comparing RIG with PEG

    Immediately after procedure completion

  • Anesthesia type associated with gastrostomy tube placement, comparing RIG with PEG

    Immediately after procedure completion

  • Patient quality of life associated with gastrostomy tube placement, comparing RIG with PEG, before and after the procedure

    Before the procedure

  • Patient quality of life associated with gastrostomy tube placement, comparing RIG with PEG, before and after the procedure

    At 6 weeks after procedure

Study Arms (2)

PEG Group

ACTIVE COMPARATOR

Subjects will gastrostomy tube placement via percutaneous endoscopic gastrostomy (PEG) method.

Procedure: Percutaneous endoscopic gastrostomy

RIG Group

ACTIVE COMPARATOR

Subjects will have the placement of a gastrostomy tube via radiologically-inserted gastrostomy (RIG) method.

Procedure: Radiologically-inserted gastrostomy

Interventions

Gastrostomy tube placement using an endoscopic camera inserted via the mouth into the stomach to place the tube.

PEG Group

Gastrostomy tube placement using a temporary nasogastric tube placed from nose to stomach and fluoroscopy (x-rays).

RIG Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18 years
  • Cannot maintain adequate nutrition by mouth

You may not qualify if:

  • Venting-only gastrostomy
  • Patients with Amyotrophic Lateral Sclerosis (ALS)
  • Coagulopathy with uncorrectable International Normalized Ratio (INR) greater than 1.5 or inability to hold anticoagulation
  • Structural abnormality that would prevent one or both techniques
  • Known severe esophageal stricture
  • Obstructing malignancy in oropharynx or esophagus that prohibits pull-through technique
  • Neoplastic, inflammatory, or infiltrative disease of abdominal wall or gastric wall
  • Known hepatomegaly
  • Abdominal wall mesh
  • Enteric functional abnormality
  • Small bowel or colonic obstruction
  • Gastric or small bowel dysmotility
  • Active abdominal infection/peritonitis/enterocutaneous fistula
  • Ascites
  • Ventriculoperitoneal shunt
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Melissa Neisen, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants are randomized to receive either RIG or PEG. Investigator and Outcomes Assessors are masked.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 29, 2021

First Posted

December 30, 2021

Study Start

December 8, 2017

Primary Completion

July 29, 2021

Study Completion

July 29, 2021

Last Updated

January 11, 2023

Record last verified: 2023-01

Locations